Net income per ordinary share: | ||||
|
| Year ended December 31, | Three Months ended December 31, | ||
|
| 2020 | 2019 | 2020 | 2019 |
|
| U.S. dollars | U.S. dollars | ||
|
|
|
|
|
|
Basic earnings from continuing operation | 0.55 | 0.55 | 0.19 | 0.12 |
|
|
|
|
|
|
Basic earnings from discontinued |
|
|
|
|
operation * | - | 0.03 | - | - |
|
|
|
|
|
|
Basic net earnings | 0.55 | 0.58 | 0.19 | 0.12 |
|
|
|
|
|
|
Diluted earnings from continuing |
|
|
|
|
operation | 0.54 | 0.54 | 0.18 | 0.12 |
|
|
|
|
|
|
Diluted earnings from discontinued |
|
|
|
|
operation * | - | 0.03 | - | - |
|
|
|
|
|
|
Diluted net earnings | 0.54 | 0.57 | 0.18 | 0.12 |
|
|
|
|
|
|
Weighted average number of |
|
|
|
|
ordinary shares outstanding: |
|
|
|
|
|
|
|
|
|
|
Basic | 39,383 | 37,626 | 40,894 | 38,630 |
|
|
|
|
|
|
Diluted | 40,372 | 38,432 | 41,964 | 39,497 |
Reconciliation of GAAP To Non-GAAP results | ||||
|
| ||||
(In thousands, except share data) | ||||
|
| Year ended December 31, | Three Months ended December 31, | ||
|
| 2020 | 2019 | 2020 | 2019 |
|
| U.S. dollars | U.S. dollars | ||
|
|
|
|
|
|
Reported net income attributable to
| 21,778 | 21,986 | 7,666 | 4,607 |
Share-based compensation | 4,224 | 2,892 | 1,171 | 824 |
| Chroma transaction expenses (1) | - | 136 | - | - |
| Attributable to discontinued operations | - | (1,163) | - | - |
| Non-GAAP net income | 26,002 | 23,851 | 8,837 | 5,431 |
|
|
|
|
|
|
| Non–GAAP net income per diluted share | 0.63 | 0.62 | 0.21 | 0.14 |
| Gross margin on GAAP basis | 47.0% | 48.3% | 47.9% | 47.7% |
| Reported gross profit on GAAP basis | 73,321 | 64,784 | 23,306 | 15,841 |
| Share-based compensation | 429 | 292 | 121 | 85 |
| Non-GAAP gross margin | 47.3% | 48.6% | 48.2% | 48.0% |
| Non-GAAP gross profit | 73,750 | 65,076 | 23,427 | 15,926 |
|
|
|
|
|
|
| Reported operating income (loss)
|
22,624 |
21,972 |
8,025 |
4,588 |
| Share-based compensation | 4,224 | 2,892 | 1,171 | 824 |
| Chroma transaction expenses (1) | - | 136 | - | - |
| Non-GAAP operating income | 26,848 | 25,000 | 9,196 | 5,412 |
|
| ||||
|
| ||||
|
| ||||
|
| ||||
| (1) In the second and third quarters of 2019, certain transaction expenses were incurred in relation to the technological cooperation agreement with Chroma. These were recorded under operating expenses. | ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
